Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.56M | -3.03M | -5.32M | -9.25M | -8.58M |
| Total Depreciation and Amortization | 127.40K | 129.40K | 145.30K | 141.40K | 129.70K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 1.49M | -- |
| Total Other Non-Cash Items | 15.06M | 1.94M | 1.32M | 6.75M | 3.90M |
| Change in Net Operating Assets | -3.30M | 652.20K | 2.13M | -1.08M | 284.20K |
| Cash from Operations | -1.67M | -305.60K | -1.72M | -1.95M | -4.26M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.89M | 350.70K | 408.40K | -1.36M | -1.35M |
| Cash from Investing | -2.89M | 350.70K | 408.40K | -1.36M | -1.35M |
| Total Debt Issued | 2.73M | 11.10K | 271.60K | 1.96M | 3.11M |
| Total Debt Repaid | -1.02M | -758.90K | -10.20K | -819.10K | -23.30K |
| Issuance of Common Stock | 5.40M | 337.90K | 0.00 | 145.90K | 45.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -108.60K | 1.82M | -- | -- | -- |
| Cash from Financing | 7.00M | 1.41M | 261.40K | 1.29M | 3.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.44M | 1.46M | -1.05M | -2.02M | -2.48M |